There is no doubt that ETF trading is becoming an interesting topic for many people. The Exchange-Traded Funds market is very detailed. There are many different types of trading in this market and there are many moving parts when one starts ETF trading. This is a very brief look at the advantages of ETF trading and some information that may be helpful to a person who is just being introduced to ETF.

There are many benefits to ETF trading but a person needs to know that the “history” referred to in ETF is relative. The major players in ETF trading are large financial firms that have a strong history and background in the stock market. ETF itself began being actively-managed in 2008. When one looks for a “history” of success with ETF they will want to look to the firms that have a history of success on Wall Street.

Another factor in …

We all invest in stocks for the same reason, to make money. However, investment styles can be as unique as fingerprints. Amazingly, investor surveys show that most of us do have one thing in common…we love small cap stocks.

Typically, the higher potential returns is what draws us to these smaller companies even though they carry higher risk. Research clearly shows that small caps outperform the rest of the market by a wide margin. Most investors would agree its worth bearing that extra risk.

Why do small caps outperform? And why should you consider putting even more of your money into these stocks? Read on for the answers.

Who Doesn't Want to Beat the Market?

As I said earlier, we are all in the market to make money, so why not be in stocks that outperform the S&P 500 by 20%? Yes, 20%. In a study conducted over the 80 years prior to

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday November 6, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) announced recently that it has signed Miura Engineering Co., Ltd. Tokyo, Japan (www.miura21.co.jp) as its new agent to serve markets in Japan for CTI’s Nano-Cavitation Process Systems. Miura is a leading Engineering Company specialized in Edible Oil Processing Plants in the Far East. Last week CVAT reported a 3-for-1 forward stock split.

Hong Kong Highpower Technology, Inc. (NYSE Amex: HPJ), a developer, manufacturer and marketer of nickel-metal hydride (Ni-MH) and

...

Baltimore-(TFN):Time to panic? If you are part of the Obama administration the answer is yes. If you are an American investor, hold off on the freaking out for at least another month or so.

With the nation’s unemployment rate officially in double-digit territory and the under-employed rate ready to the 20% mark, the politicians that promised bliss in the days ahead are eating their words today.

And that means Wall Street is eating its recent gains.

For nearly a month, the Dow has hovered around the 10,000 mark. After hundreds of billions of dollars were withdrawn earlier this year, it was relatively easy to put that money back to work and send the equities market higher.

But now that the economic data is showing facts of slower-than-expected expansion rather than “ideas” of growth, investors are forced to explain their logic. The Dow doesn’t want to budge from 10k.

So far, I’ve heard very

...

Doctor Up Your Portfolio With This Medical Communications Company

by Louise Harris, Investment U Research

The healthcare reform debate continues to swirl in Washington. And Marc Lichtenfeld and Louis Basenese have discussed this crucial topic recently, offering their thoughts on the companies best positioned to profit.

That’s because regardless of the back-and-forth and political slanging match, the healthcare sector still offers strong potential for solid returns, due to skyrocketing demand.

In particular, one small-cap poised for gains is the Utah-based firm ZYTO Corp. (OTC: ZYTC). It focuses on medical communication software and services, including an operating system that transfers information from computers to humans.

But ZYTO goes beyond simple data input. It uses patent-pending methods that monitor biological states in near-real time, creating a stimulus-response experience called a bio-survey.

(Translation: It reads life signs and converts them into easily readable

...

Put These Two Promising Biotech Stocks on Your Watch List

by Louis Basenese, Small Cap and Special Situations Expert Friday, November 6, 2009: Issue #1132

All the hoopla surrounding the biotech stock, Dendreon Corp. (Nasdaq: DNDN), this year is well deserved.

After all, the market potential for its prostate cancer treatment, Provenge, is significant. This year, 190,000 new cases of prostate cancer are expected, with 27,000 deaths from the disease. That makes it the most common non-skin cancer in the United States and the third most common cancer worldwide.

But Provenge takes a novel approach to treatment. The drug is the first active immunotherapy to improve survival by training a patient’s immune system to attack the cancer. And since it uses the body’s natural defenses, patients only report flu-like symptoms instead of the nasty side effects associated with chemotherapy.

This

...

MedClean Technologies Inc. traded as high as $0.018 a share today, up $0.011 or 157% from yesterday’s close. The number of shares traded so far has been an incredible 42.5 million shares, swamping its average daily volume of about 467,000 shares. MedClean Technologies was mentioned in the FREE Daily QualityStocks Newsletter back on July 28, 2009. At the time, the stock was trading at only $0.0012 a share. Don’t let the decimal point throw you – the stock has multiplied more than 10 times since then!

The company was founded in 1997 and changed its name to MedClean Technologies in January 2009. It is the premier designer and manufacturer of on-site regulated medical waste processing systems and related services. The company provides MedClean series systems as solutions to incineration or off-site hauling of untreated medical waste, and also various other alternative treatment technologies and methodologies.

MedClean Technologies is just the type of

...

I’m always interested in how Government ties in with the markets. It’s been a bit of a hobby of mine, along with WWII battles, over the past 2-3 years and there’s no bigger tie then Goldman and the Government then recently…and BOY is it bigger then we know! In my recent late night surfing I came across Greg Roy. Greg recently released a special report with the same title of this blog post, Goldman Sachs’ Next Slaughter of the Stock Market Lambs, and being the digger I am, I read the full report and cold called him. I asked if I could repost a part of the report for my Trader’s Blog members. After some convincing he said ok.

This guy knows what he is talking about… Here is an exclusive excerpt from his newly released report Goldman Sachs’ Next Slaughter of the Stock Market Lambs.

===================================================================

Goldman Sachs

...

Dan Holland has just interviewed Wall Street chronicler Charlie Gasparino’s. The first few paragraphs of the interview that appeared on RealClearMarkets are published below.

There’s good reason to believe that Gasparino’s latest book, The Sellout, will become the definitive book on the current financial crisis and the events that led up to “The Great Recession.” Spanning three decades, The Sellout pulls no punches in chronicling the rise and fall of excessive Wall Street leverage and risk taking, as well as the cast of colorful characters that ultimately brought the US financial system to its knees. It will hit bookshelves tomorrow [Tuesday].

RealClearMarkets: You sat down recently with Wall Street legend Teddy Forstmann to discuss your new book and the genesis of the mess we now find ourselves in. Forstmann said it all began as a “cold” back in the 1970s and 1980s, and that since

...

Two Investments to Add to Your “Green” Portfolio

by Louise Harris, Investment U Research

Green investing can be tricky.

That was evidenced after oil prices dropped last year and alternative energy companies saw their profits fall just as quickly.

Naturally, investor enthusiasm followed, as green ETFs like Claymore/Mac Global Solar Energy Index (NYSE: TAN) and Market Vectors Solar Energy (NYSE: KWT) have tumbled 45% over the past 12 months.

Similarly, the broad alternative energy portfolio PowerShares WilderHill Clean Energy (NYSE: PBW), has declined by an average of 13.5% annually for the last three years.

But despite those woes, the alternative energy sector still has a few things going for it…

Popularity: The more scientists talk about climate change and how to prevent greenhouse emissions, the more popular alternative energies become. This is especially true in Europe, ...